7/11/2023Bayer Extends Partnership with PKU to Foster Pharma Innovation in Chin...

7/11/2023Novartis Returns $300M Candidate to BeiGene as It Retreats from TIGIT ...

7/11/2023BeiGene and DualityBio Announce Partnership to ADC Drug Conjugate Ther...

7/11/2023NMPA Issues the Technical Guidelines for Clinical Trials of Human Papi...

7/11/2023BioNTech and Doer Biologics Enter Biotherapeutic Licensing Deal

7/11/2023Hepatitis B Burden Places China at An Elevated Risk of Liver Cancer: G...

7/10/2023CDE Issues the Principles for the Identification, Management, and Eval...

7/10/2023NMPA Solicits Comments on the CDE Work Procedures for Safety Informati...

7/10/2023WuXi Biologics Announces Proposed Spin-off and Separate Listing of WuX...

7/10/2023Tapping New and Improved Drug Innovations in Asia (PharmExec)

7/7/2023NHC Establishes National-level Medical Emergency Response Expert Group

7/7/2023Recent Executive Moves

7/7/2023Drug R&D and Product Registration News Digest July 2023 (1)

7/6/2023Sirnaomics Establishes a Strategic Partnership with RNA-Editing Firm E...

7/6/2023VBI and Brii Expand Hepatitis B Partnership

7/6/2023Takeda and Sino Biopharma's Five Star Join Hands to Develop New Genera...

7/5/2023Moderna Set to Make First Investment of $1B in China: Sources

7/5/2023NMPA Issues the Provisions on Drug Standards

7/5/2023NMPA and Chinese Customs Announce the Customs Commodity Codes of Oxeli...

7/5/2023Biocytogen and Pheon Enter Antibody License Pact

7/5/2023China Offers An Olive Branch to Frustrated MNC Pharma Firms: Reuters

7/5/2023Soliris Approval to Allow AstraZeneca A Key Role in Rare Disease Spac...

7/5/2023SMEI Forecasts Growth of Ex-Hospital and Innovative Drug Sales Before ...

7/4/2023AbbVie Terminates Collaboration with Jacobio for SPH2 Inhibitors

7/4/2023CDE Issues the Announcement for Applicability of ICH Guideline M10 Q&A...

7/4/2023CDE Publicizes the List of Reference Formulations for GQCE Studies (72...

7/4/2023NHSA Solicits Comments on the Rules for Contract Renewal of Negotiated...

7/3/2023CDE Issues the Guidelines for Acceptance and Evaluation of APIs (Trial...

7/3/2023NMPA Solicits Comments on the Draft Measures for the Supervision and I...

7/3/2023Snapshot of NRDL Inclusion and Hospital Listing of New Drugs Approved ...

Page:97/775 Total number of articles:23243: [First][<<] [95] [96] [97] [98] [99] [>>] [End]